Joincare Pharmaceutical Group Industry Co.,Ltd. (SHA: 600380)

China flag China · Delayed Price · Currency is CNY
12.10
+0.23 (1.94%)
Nov 11, 2024, 3:00 PM CST
0.08%
Market Cap 22.51B
Revenue (ttm) 15.89B
Net Income (ttm) 1.47B
Shares Out 1.87B
EPS (ttm) 0.78
PE Ratio 15.31
Forward PE 14.74
Dividend 0.18 (1.49%)
Ex-Dividend Date Jul 18, 2024
Volume 31,394,988
Open 11.80
Previous Close 11.87
Day's Range 11.64 - 12.19
52-Week Range 9.40 - 13.25
Beta 0.42
Analysts n/a
Price Target n/a
Earnings Date Oct 25, 2024

About Joincare Pharmaceutical Group Industry Co.,Ltd.

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products. It also provides chemical APIs and intermediates; diagnostic reagents... [Read more]

Sector Healthcare
Founded 1992
Employees 14,365
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600380
Full Company Profile

Financial Performance

In 2023, Joincare Pharmaceutical Group Industry Co.,Ltd.'s revenue was 16.65 billion, a decrease of -2.90% compared to the previous year's 17.14 billion. Earnings were 1.44 billion, a decrease of -3.99%.

Financial Statements

News

There is no news available yet.